Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03147872 · ClinicalTrials.gov registry record · NA
Evaluation of the Impact of Reduced Oxygen Concentration on Live Birth Rate
A NA study, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 280
- Enrollment target
NCT03147872 is a NA study that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 280 participants.
The verdict
NCT03147872, a NA study, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
Study Summary
Clinical in vitro fertilization relies on successful embryo culture. The primary goal of embryo culture is to attempt to recapitulate the in vivo conditions as much as possible. In the past decade, the majority embryo culture has been performed at 5% oxygen due to the discovery that the oxygen tension in the fallopian tube (where the embryo is located for the first 3 days after fertilization) is 5%. However, relatively recent studies have demonstrated that the oxygen tension in the uterus (where the embryo is located after day 3) is closer to 2%. This study is a randomized controlled trial that will compare pregnancy rates between embryos cultured in 2% versus 5% after day 3 of development.
Interventions
- OTHER 2% Oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2021-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03147872
The ClinicalTrials.gov registry entry for NCT03147872 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2% Oxygen is the first listed.
NCT03147872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03147872 about?
NCT03147872 is a clinical study titled "Evaluation of the Impact of Reduced Oxygen Concentration on Live Birth Rate". Clinical in vitro fertilization relies on successful embryo culture. The primary goal of embryo culture is to attempt to recapitulate the in vivo conditions as much as possible. In the past decade, the majority embryo culture has been performed at 5% oxygen due to the discovery that the oxygen tensi...
What is the current status of trial NCT03147872?
This trial is currently completed. It is a NA study. The enrollment target is 280 participants. The study started on 2017-05-15. Estimated completion is 2021-01-31.
What interventions are being tested in trial NCT03147872?
The interventions under investigation include: 2% Oxygen (OTHER).
Who is sponsoring clinical trial NCT03147872?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.